ANEB-001
AN01AC11
Phase 2 small_molecule completed
Quick answer
ANEB-001 for Acute Cannabinoid Intoxication is a Phase 2 program (small_molecule) at Anebulo Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Anebulo Pharmaceuticals
- Indication
- Acute Cannabinoid Intoxication
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed